We are live on ! Find out more
EBS icon

Emergent Biosolutions

208 hedge funds and large institutions have $1.17B invested in Emergent Biosolutions in 2016 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 76 increasing their positions, 67 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $804K

32% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 28

13% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 67

2% more funds holding

Funds holding: 203208 (+5)

2% more capital invested

Capital invested by funds: $1.15B → $1.17B (+$24.6M)

2.25% less ownership

Funds ownership: 90.5%88.25% (-2.2%)

Holders
208
Holders Change
+5
Holders Change %
+2.46%
% of All Funds
5.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
37
Increased
76
Reduced
67
Closed
28
Calls
$1.32M
Puts
$804K
Net Calls
+$513K
Net Calls Change
-$2.49M
Name Holding Trade Value Shares
Change
Change in
Stake
BA
101
BlackRock Advisors
Delaware
$1.02M -$1.44M -48,143 -61%
SEI Investments
102
SEI Investments
Pennsylvania
$1.01M +$918K +30,631 +14,942%
Ohio Public Employees Retirement System (OPERS)
103
Ohio Public Employees Retirement System (OPERS)
Ohio
$988K +$52.4K +1,747 +6%
VIA
104
Vident Investment Advisory
Georgia
$962K +$49.1K +1,639 +6%
First Trust Advisors
105
First Trust Advisors
Illinois
$909K +$830K +27,677 New
WC
106
Woodstock Corp
Massachusetts
$904K -$168K -5,606 -17%
State of Tennessee, Department of Treasury
107
State of Tennessee, Department of Treasury
Tennessee
$896K
PP
108
Paloma Partners
Connecticut
$895K +$442K +14,733 +118%
VRS
109
Virginia Retirement Systems
Virginia
$887K
Macquarie Group
110
Macquarie Group
Australia
$870K +$794K +26,500 New
PAM
111
Paradigm Asset Management
New York
$841K -$288K -9,600 -27%
TPSF
112
Texas Permanent School Fund
Texas
$825K -$32.7K -1,090 -4%
CIA
113
Capital Impact Advisors
Massachusetts
$809K
Public Sector Pension Investment Board (PSP Investments)
114
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$797K
AIG
115
American International Group
New York
$792K -$10.9K -362 -1%
MLICM
116
Metropolitan Life Insurance Company (MetLife)
New York
$765K
State Board of Administration of Florida Retirement System
117
State Board of Administration of Florida Retirement System
Florida
$703K
ADEF
118
Adams Diversified Equity Fund
Maryland
$703K +$426K +14,200 +197%
BA
119
Boston Advisors
Massachusetts
$679K +$262K +8,730 +73%
SAM
120
Shell Asset Management
Netherlands
$659K -$5.25K -175 -0.9%
CSS
121
Cubist Systematic Strategies
Connecticut
$594K +$542K +18,077 New
ASRS
122
Arizona State Retirement System
Arizona
$583K
BCM
123
Bridgeway Capital Management
Texas
$581K -$69K -2,300 -12%
CG
124
Clinton Group
New York
$564K -$445K -14,856 -46%
M&T Bank
125
M&T Bank
New York
$555K +$87K +2,903 +21%

EBS Hedge Fund Activity: Q4 2016 in Review

208 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q4 2016, worth a combined $1.17B — up 2.1% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new EBS positions and 28 closed out — a net gain of 9 holders — while 76 added to existing stakes and 67 trimmed.

The largest buyer was Royal Bank of Canada, adding an estimated $12M. The largest seller was Arrowstreet Capital, exiting entirely with an estimated $23.3M sold.

  • 208 institutional investors held Emergent Biosolutions (EBS) as of Q4 2016, up from 203 in Q3 2016.
  • Funds reported $1.17B of Emergent Biosolutions stock for Q4 2016, up 2.1% quarter-over-quarter.
  • 37 funds opened new Emergent Biosolutions positions in Q4 2016 and 28 closed out, a net change of +9 holders.
  • The largest Emergent Biosolutions buyer in Q4 2016 was Royal Bank of Canada, an estimated $12M added.
  • The largest Emergent Biosolutions seller in Q4 2016 was Arrowstreet Capital, an estimated $23.3M sold.

Based on aggregated 13F filings for Q4 2016.